Federal Circuit Affirms Decision Preventing Generic Lyrica, Finding Sparse Evidence of Obviousness

A three judge panel of the Federal Circuit recently affirmed the District of Delaware’s judgment of infringement and validity related to U.S. Patent No. 6,197,819 (owned by Northwestern University and licensed to Pfizer) covering the drug Lyrica,...
By: Carlson Caspers